Therapeutic potential of 5‐[¹²⁵I]iodo‐2′‐deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis

References

• BAGSHAWE, K. D., SHARMA, S. K., SOUTHALL, P. J., BODEN, J. A., BOXER, G. M., PATRIDGE, T. A., ANTomw, P. and PEDLEY, R. B., 1991, Selective uptake of toxic nucleoside (125IUdR) by resistant cancer. The British Journal of Radiology, 64, 37–44.
   PubMed Web of Science ®Google Scholar
• BERRY, M. P., JENKIN, R. D. T., KEEN, C. W., NAIR, B. D. and SIIVIPSON, W. J., 1981, Radiation treatment for medulloblastoma: a 21-year review. Journal of Neuro-surgery, 55, 43–51.
   Google Scholar
• BLEYER, W. A., DRAKE, J. C. and CHABNER, B. A., 1973, Neurotoxicity and elevated cerebrospinal-fluid metho-trexate concentration in meningeal leukemia. The New England Journal of Medicine, 289, 770–773.
   PubMed Web of Science ®Google Scholar
• BRADLEY, E. W., CHAN, P. C. and ADELSTEIN, S. J., 1975, The radiotoxicity of iodine-125 in mammalian cells I. Effects on the survival curve of radioiodine incorporated into DNA. Radiation Research, 64, 555–563.
   PubMed Web of Science ®Google Scholar
• CHARLTON, D. E. and Booz, J., 1981, A Monte Carlo treatment of the decay of 1251. Radiation Research, 87, 10–23.
   PubMed Web of Science ®Google Scholar
• DEANGELIS, L. M., 1998, Current diagnosis and treatment of leptomeningeal metastasis. Journal of Neuro-oncology, 38, 245–252.
   PubMed Web of Science ®Google Scholar
• EIDINOFF, M. L., CHEONG, L., GAMBETTA GURPIDE, E., BENUA, R. S. and ELLISON, R. R., 1959, Incorporation of 5-iodouracil labelled with iodine-131 into the deoxyribonucleic acid of human leukaemic leucocytes following in vivo administration of 5-iododeoxyuridine labelled with iodine-131. Nature, 183, 1686–1687.
   Google Scholar
• FOULON, C. F., ADELSTEIN, S. J. and KASSIS, A. I., 1996, Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation. The Journal of Nuclear Medicine, 37(4, suppl.), 1S–35.
   Google Scholar
• GARRETT, C., WATAYA, Y. and SANT', D. V., 1979, Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2'-deoxyuridylate. Biochemistry, 18, 2798–2804.
   Google Scholar
• GROSSMAN, S. A. and MoYmITAN, T. J., 1991, Neoplastic meningitis. Neurologic Clinics, 9, 843–856.
   PubMed Web of Science ®Google Scholar
• GROSSMAN, S. A., FINKELSTEIN, D. M., RUCKDESCHEL, J. C., TRUMP, D. L., MOYNIHAN, T. and ETTINGER, D. S. for the Eastern Cooperative Oncology Group, 1993, Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Journal of Clinical Oncology, 11, 561–569.
   Google Scholar
• HOFER, K. G. and HUGHES, W. L., 1971, Racliotoxicity of intranuclear tritium, 125iodine and 131iocline. Radiation Research, 47, 94–109.
   PubMed Web of Science ®Google Scholar
• KASSIS, A. I., SASTRY, K. S. R. and ADELSTEIN, S. J., 1985, Intracellular localisation of Auger electron emitters: biophysical dosimetry. Radiation Protection Dosimetry, 13, 233–236.
   Google Scholar
• KASSIS, A. I., FAYAD, F., KINSEY, B. M., SASTRY, K. S. R., TAUBE, R. A. and ADELSTEIN, S. J., 1987a, Radiotoxicity of 1251 in mammalian cells. Radiation Research, 111, 305–318.
   Google Scholar
• KASSIS, A. I., SASTRY, K. S. R. and ADELSTEIN, S. J., 1987b, Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiation Research, 109, 78–89.
   Google Scholar
• KASSIS, A. I., HOWELL, R. W., SASTRY, K. S. R. and ADELSTEIN, S. J., 1988, Positional effects of Auger decays in mammalian cells in culture. In DNA Damage by Auger Emitters, edited by K. F. Baverstock and D. E. Charlton (London: Taylor and Francis), pp 1–13.
   Google Scholar
• KASSIS, A. I., MAKRIGIORGOS, G. M. and ADELSTEIN, S. J., 1990, Implications of radiobiological and dosimetric studies of DNA-incorporated 1231: the use of the Auger effect as a biological probe at the nanometre level. Radiation Protection Dosimetry, 31, 333–338.
   Web of Science ®Google Scholar
• KASSIS, A. I., ADELSTEIN, S. J. and MAIUANI, G., 1996, Racliolabeled nucleoside analogs in cancer diagnosis and therapy. The Quarterly Journal of Nuclear Medicine, 40, 301–319.
   PubMedGoogle Scholar
• KAssis, A. I., DAHNAAN, B. A. and ADELSTEIN, S. J., 2000, In vivo therapy of neoplastic meningitis with methotrexate and 5-[125[] iodo-2'-deoxyuridine. Acta Oncologica, 39, 731–737.
   PubMed Web of Science ®Google Scholar
• MACKINTOSH, F. R., COLBY, T. V., PODOLSKY, W. J., BURKE," S., HOPPE, R. T., ROSENFELT, F. P., ROSENBERG, S. A. and KAPLAN, H. S., 1982, Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer, 49, 586–595.
   Google Scholar
• MARIAN', G., Di SACCO, S., BONIN', R., Di LUCA, L., BURALLI, S., BONORA, D., Ricci, S., BARANOWSKA-KORTYLEWICZ, J., ADELSTEIN, S. J., FALCONE, A. and KAssts, A. I., 1996, Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 541231]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. Acta Oncologica, 35, 941–945.
   PubMedGoogle Scholar
• MESTER, J., DEGOEU, K. and SLUYSER, M., 1996, Modulation of [5-1251]iodo-deoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors. European Journal of Cancer, 32A, 1603–1608.
   Google Scholar
• PATCHELL, R. A. and POSNER, J. B., 1985, Neurologic complications of systemic cancer. Neurologic Clinics, 3, 729–750.
   PubMed Web of Science ®Google Scholar
• PORTEOUS, D. D., 1971, The toxicity of 1251UclR in cultured mouse BP8 tumour cells. British Journal of Cancer, 25, 594–597.
   PubMedGoogle Scholar
• SHAPIRO, W. R., POSNER, J. B., Usmo, Y., CHERNIK, N. L. and YOUNG, D. F., 1977, Treatment of meningeal neoplasms. Cancer Treatment Reports, 61, 733–743.
   PubMedGoogle Scholar
• STEWART, D. J., KEATING, M. J., MCCREDIE, K. B., SMITH, T. L., YOUNESS, E., MURPHY, S. G., BODEY, G. P. and FREIREICH, E. J., 1981, Natural history of central nervous system acute leukemia in adults. Cancer, 47, 184–196.
   PubMed Web of Science ®Google Scholar
• TRUMP, D. L., GROSSMAN, S. A., THOMPSON, G., MURRAY, K. and WHARA MM., 1982, Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate. Cancer Treatment Reports, 66, 1549–1551.
   PubMedGoogle Scholar
• WALICKA, M. A., ADELSTEIN, S. J. and KASSIS, A. I., 1998, Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiation Research, 149, 134–141.
   PubMed Web of Science ®Google Scholar
• WARTERS, R. L. and HOFER, K. G., 1977, Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation-induced division delay. Radiation Research, 69, 348–358.
   PubMed Web of Science ®Google Scholar
• WASSERSTROM, W. R., GLASS, J. P. and POSNER, J. B., 1982, Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer, 49, 759–772.
   PubMed Web of Science ®Google Scholar
• WINKELMAN, M. D. and HINES, J. D., 1983, Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Annals of Neurology, 14, 520–527.
   PubMedGoogle Scholar
• XUE, L. Y., BUTLER, N. J., MAKRIGIORGOS, G. M., ADELSTEIN, S. J. and KAssis, A. I., 2002a, Bystander effect produced by racliolabeled tumor cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 99, 13765–13770.
   PubMed Web of Science ®Google Scholar
• XUE, L. Y., BUTTER, N. J., KIRICHIAN, A. M., ADELSTEIN, S. J. and KAssis, A. I., 2002b, Methotrexate enhances potential of 5-125I-iodo-2'-deoxyuricline in the treatment of neoplastic meningitis. The Journal of Nuclear Medicine, 43(5, suppl.), 278P.
   Google Scholar